Lung damage in patients with COVID-19 might be preventable using an antiparasitic drug that is commonly employed to treat tapeworm infections, a study has found.
Supported by the British Heart Foundation, the researchers used robotic technology to screen more than 3,000 approved drugs for use against the novel coronavirus.
They found that Niclosamide blocks a protein which COVID-19 uses to force infected cells to merge with their neighbours and it can also reduce cell death from the virus.
Sales are slow on this drug, so let’s come up with another outlandish unproven use for it to make lots of money.